Hong Kong stocks change | Kangsinuo biological up 5% expected 2021 revenue significantly increased 168-176 times

2022-04-28 0 By

Glonhui Jan 31 / Consino Bio (6185.HK) rose 5.32% to HK $130.6, giving it a market cap of HK $32.3 billion.Consino Bio-B reported a profit on Monday, predicting that it will achieve a net profit of 1.85 billion to 2 billion yuan for its attributable shareholders in 2021, compared with a loss of 397 million yuan in 2020.The annual revenue was between 4.2 billion and 4.4 billion yuan, a substantial increase of 168-176 times.During the year, the company’s recombinant Novel Coronavirus vaccine (trade name: Kwiksha) was approved by the State Medical Products Administration for conditional marketing in China and received emergency authorization for use in several overseas countries, which had a positive impact on revenue and net profit.